Abstract
Due to its distinct biological attributes, poly(d,l lactide-co glycolide) (PLGA) is one of the most preferred methods for DNA/protein/peptide encapsulation for therapeutics. Importantly, PLGA acts as an adjuvant for weakly immunogenic antigens and mimics booster responses after a single dose of administration, thereby serving as a single-shot vaccine delivery vehicle. Efficient delivery of antigens to antigen-presenting cells (APC) has been made possible by the use of a PLGA particle-based vaccine delivery system. Also, the plasma half-life of the PLGA-encapsulated vaccine increases as it is protected from degradation, prior to its further release. PLGAs are reported to be catabolized into individual nontoxic units once inside the host and further degraded via normal metabolic pathways. In this chapter, we have described the preparation and characterization of tumor peptide encapsulated PLGA microparticles as a model for controlled-release peptide delivery system.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Owusu-Ababio G, Rogers JA (1996) Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres. J Microencapsul 13(2):195–205
Dinarvand R et al (2006) Preparation, characterization and in vitro drug release properties of polytrimethylene carbonate/polyadipic anhydride blend microspheres. J Appl Polym Sci 101(4):2377–2383
Shokri N et al (2011) Preparation and evaluation of poly (caprolactone fumarate) nanoparticles containing doxorubicin HC1. Daru 19(1):12–22
Yousefpour P et al (2011) Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab. Int J Nanomedicine 6:1977–1990
Dinarvand R et al (2011) Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine 6:877–895
Edlund U, Albertsson AC (2002) Degradable polymer microspheres for controlled drug delivery. Adv Polymer Sci 157:67–112
Muthu MS (2009) Nanoparticles based on PLGA and its copolymer: an overview. Asian J Pharm 3:266–273
Par T (1994) Degradation of poly (D, L-lactic acid) microspheres: effect of molecular weight. J Control Release 30(2):161–173
Budhian A et al (2007) Haloperidol-loaded PLGA nanoparticles: systemic study of particle size and drug content. Int J Pharm 336: 367–375
Benoit MA et al (1999) Preparation and characterization of protein-loaded poly (ε-caprolactone) microparticle for oral vaccine delivery. Int J Pharm 184:73–84
Cryan SA (2005) Carrier based strategies for targeting protein and peptide drugs to the lungs. AAPS J 7(1):E20–E41
Jiang W et al (2005) Biodegradable poly (lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 57:391–410
Khan AA et al (2008) Identifying B and T epitopes and studying humoral, mucosal and cellular immune response of V antigen of Y. pestis. Vaccine 26:316–332
Jayaprakash Babu US et al (2011) Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide comprising of defined epitopes of LcrV antigen of Yersinia pestis coupled to palmitate in mice. Vaccine 29: 9352–9360
Desai MP et al (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13:1838–1845
Diaz RV et al (1999) One month sustained release microspheres of 125-I-bovine calcitonin: in vitro–in vivo studies. J Control Release 59: 55–62
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Bhatnagar, S., Naqvi, R.A., Ali, R., Rao, D.N. (2014). Preparation of Peptide Microspheres Using Tumor Antigen-Derived Peptides. In: Lawman, M., Lawman, P. (eds) Cancer Vaccines. Methods in Molecular Biology, vol 1139. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0345-0_34
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0345-0_34
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0344-3
Online ISBN: 978-1-4939-0345-0
eBook Packages: Springer Protocols